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Interaction modulation through arrays of clustered
methyl-arginine protein modifications
Jonathan Woodsmith1,2 , Victoria Casado-Medrano2,3, Nouhad Benlasfer2, Rebecca L Eccles4, Saskia Hutten5,
Christian L Heine1, Verena Thormann2, Claudia Abou-Ajram5, Oliver Rocks6, Dorothee Dormann5,7 , Ulrich Stelzl1,2
Systematic analysis of human arginine methylation identifies two
distinct signaling modes; either isolated modifications akin to
canonical post-translational modification regulation, or clus-
tered arrays within disordered protein sequence. Hundreds of
proteins contain these methyl-arginine arrays and are more
prone to accumulate mutations and more tightly expression-
regulated than dispersed methylation targets. Arginines within
an array in the highly methylated RNA-binding protein synapto-
tagmin binding cytoplasmic RNA interacting protein (SYNCRIP)
were experimentally shown to function in concert, providing
a tunable protein interaction interface. Quantitative immuno-
precipitation assays defined two distinct cumulative binding
mechanisms operating across 18 proximal arginine–glycine (RG)
motifs in SYNCRIP. Functional binding to the methyltransferase
PRMT1 was promoted by continual arginine stretches, whereas
interaction with the methyl-binding protein SMN1 was arginine
content–dependent irrespective of linear position within the
unstructured region. This study highlights how highly repetitive
modifiable amino acid arrays in low structural complexity re-
gions can provide regulatory platforms, with SYNCRIP as an
extreme example how arginine methylation leverages these
disordered sequences to mediate cellular interactions.
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Introduction
Protein post-translational modifications (PTMs) are known to
regulate a vast array of cellular processes governing all facets of
human biology. A general three-tier system of PTM addition or
removal enzymes (writers and erasers) and PTM binding proteins
(readers) is used in a wide variety of differing flavors to vastly
increase the functional complexity of the human (Chen et al, 2011;
Khoury et al, 2011). Substrates can be targeted by single or
multiple modifications at any given time, leading to alterations in
expression, localization, activity, or binding partner profiles
(Woodsmith & Stelzl, 2014). The collection of tens of thousands of
annotated sites has aided computational systematic analysis into
both their evolution and interplay with one another (Beltrao et al,
2012; Minguez et al, 2012; Woodsmith et al, 2013). In particular,
recorded protein arginine methylation events increased in recent
years, facilitating their systematic study (Bremang et al, 2013; Guo
et al, 2014; Sylvestersen et al, 2014; Geoghegan et al, 2015; Larsen
et al, 2016).
Although issues remain with robust identification of methylation
sites (Hart-Smith et al, 2016), both high-throughput dataset col-
lections and small-scale studies (for an extensive review see Biggar
& Li [2015]) highlight that arginine mono- and di-methylation im-
pact a wide range of biological processes. Indeed, a recent large-
scale study identified that at least 7% of arginines in the expressed
proteome are mono-methylated (Larsen et al, 2016). Comprehen-
sive protein methylation-specific interaction networks (Weimann
et al, 2013) and methyltransferase knockout studies in cell culture
(Shishkova et al, 2017) are beginning to define a wide array of
molecular targets to support genetic studies showing the broad
impact of the nine identified arginine methyltransferase enzymes
(PRMTs) in vivo. PRMT1 and PRMT5 have been shown to be of critical
importance, displaying embryonic lethality on knockout (Pawlak
et al, 2000; Tee et al, 2010), with most other PRMTs showing different
forms of developmental or cellular defects (reviewed in detail in
Blanc& Richard [2017]). Furthermore PRMTs are well documented to
be dysregulated in cancer, with over-expression of PRMT1, CARM1
(PRMT4), and PRMT5 observed in several studies (Yang & Bedford,
2013).
On a mechanistic level, the relationship between reported
methyl-arginine sites and their cognate reader and writer proteins
has been previously studied largely using short synthesized peptides
in vitro. For example, PRMT1 and PRMT6 have been shown to prefer,
but are not limited to, arginine–glycine motifs (RG/RGG motifs
[Thandapani et al, 2013], referred to as RG motifs from here onward),
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whereas CARM1 preferentially targets proline-flanked arginines
(Osborne et al, 2007; Ko¨lbel et al, 2009; Gui et al, 2013). The methyl-
arginine binding Tudor domain has been annotated across 15 pro-
teins to date, with the isolated Tudor domain in key splicing regulator
SMN1 showing a binding preference for methylated RG motif con-
taining peptides. Furthermore, isolated Tudor domains bind peptides
withmultiplemodifications with a higher affinity than thosewith only
a singlemethyl-arginine (Tripsianes et al, 2011; Liu et al, 2012). Indeed,
many proteins have now been defined with multiple arginine
methylation sites (Larsen et al, 2016), yet the potential interplay
between modifications across full-length sequences remains poorly
studied. Furthermore, how any cooperation between modified res-
idues mechanistically mediates specific binding preferences in the
context of a writer–substrate–reader relationship in human cells is
yet unclear.
PTMs have been shown to cluster within intrinsically disordered
regions of proteins, a prevalent feature throughout the proteome
(Woodsmith et al, 2013). A select few of these regions have been
extensively studied and experimental insight into the regulation of
most of these unstructured regions is limited. Indeed, although
subsequent bioinformatic studies have improved the ways in which
to identify functional PTM clusters through integration of distinct
data types (Dewhurst et al, 2015), dissecting them mechanistically
has proved a major challenge. In vitro peptide studies have pro-
vided insight into biophysical binding properties of short modified
sequences, but cannot address the full complexity of the long
sequences identified in vivo. As the long intrinsically disordered
protein sequences that harbor these regions lay outside of the
classical structure-function paradigm, novel approaches to un-
derstanding their regulation in a cellular context are required.
Furthermore, given the vast array of human proteins that contain
modified disordered regions are also implicated in neurodegen-
erative disorders and cancer, understanding how such large re-
gions of low structural complexity are used as regulatory elements
is paramount to a better understanding of human cell biology
(Babu, 2016).
Here, we highlight that arginine methylation can be broadly
separated into two classes based on clustering prevalence, either
isolated or within modification arrays. The existence of two distinct
classes in methylated residues is supported by differences in the
structural context, mutational signatures, and expression analysis
of target proteins. We then experimentally dissected in detail the
functional requirement of a highly methylated unstructured region
in the heterogeneous nuclear RNP (hnRNP) synaptotagmin binding
cytoplasmic RNA interacting protein (SYNCRIP). To achieve a com-
prehensive overview of the entire disordered region, we took
a genetic approach to define the binding preferences of a stretch of
19 arginines in the C-terminal SYNCRIP tail using a panel of 37 full-
length mutants in quantitative immunoprecipitation experiments.
To define both the unmodified and modified states of the arginine
array, we leveraged the methyltransferase PRMT1 and the methyl-
binding protein SMN1 as functional readouts for arginine and
methyl-arginine, respectively. Remarkably, the exact same protein
sequence can mediate distinct cumulative binding mechanisms in
the modified and unmodified states. Although both interactors
increased binding concomitantly with arginine content, unmodified
arginines are preferred in continual stretches in direct contrast to
their modified counterparts that function in concert irrespective of
their position within the structurally disordered array.
This study reveals how extensive RG repeats within low structural
complexity regions can generate cumulative binding mechanisms
and, furthermore, how extensive PTMs allow for a second, distinct
recognition mode in a single repeat region.
Results
Systematic characterization of methyl-arginine array containing
proteins
To investigate systematic trends of protein methylation, we initially
obtained a list of all arginine and lysine methylation sites available
through PhosphoSitePlus (downloaded from PhosphoSitePlus.org
June 2017). These PTMs were then mapped to unique Refseq
identifiers to give 9339 arginine modifications and 4555 lysine
modifications (Table S1). We and others have previously shown that
PTMs can cluster across linear protein sequences (Beltrao et al,
2012; Woodsmith et al, 2013), a finding that has been extended to 3D
protein structures (Dewhurst et al, 2015). Although protein struc-
tures provide a more detailed viewpoint from which to study PTM
distributions, they are inherently biased against unstructured re-
gions and limited in number, and as such would impose a large
constraint on the PTM dataset. We therefore performed a sliding
window analysis that counted the number of modified residues in
stretches of 20 amino acids across a linear protein sequence (see
the Materials and Methods section). The proportion of total lysine
methylation that accumulates in short sequence stretches is
consistently lower than that of arginine methylation across mul-
tiple modification cutoffs (Fig 1A). To systematically characterize
these methylated arginine clusters, we initially investigated their
sequence context. As approximately 31% of arginine methylation
sites from HEK293T cells were recently shown to be contained
within RG motifs (Larsen et al, 2016), we analyzed the propensity of
this motif within these clustered sites. Although more dispersed
arginine methylation sites (1 or 2 methyl-Rs/20–amino acid win-
dow) recapitulate this approximate 30% RG motif content, in-
creasing densities of methylation sites correlate with a noted
increase in RGmotifs, up to 54% for ≥4methylation sites per window
(Fig 1B). These clustered, RG-motif–driven methylation sites also
correlate with a large shift toward structurally disordered regions in
comparison with isolated methyl-Rs (Fig 1C).
Arginine-methylated proteins have been shown to be involved in
multiple facets of RNA processing and binding, for example, pro-
teins containing RNA recognition motif and RNA helicase RNA–
binding domains are preferentially modified (Larsen et al, 2016). We
therefore examined the prevalence of methyl-arginine clusters
across three large-scale RNA-binding protein (RBP) PAR-Clip
studies, which have defined the RBP repertoire (Baltz et al, 2012;
Castello et al, 2012; Conrad et al, 2016). We classified protein
methylation targets based on maximum methyl-R clustering and
observed a sharp increase in the fraction of targeted proteins
annotated as RBPs with increasing modification density (Fig 1D).
This is likely a function of clustered modifications, as proteins
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Figure 1. Methyl-arginine clusters show distinct sequence, expression and mutational signatures.
(A) Bar graph showing the proportional of methyl-arginine or methyl-lysine that clusters within 20–amino acid windows. (B) Proportion of methyl-arginines that are
contained within an RGmotif in each class of 20–amino acid window. P values and odds ratio (OR) for A and B calculated using Fisher’s exact test, numbers within the bars
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targeted by many, yet dispersed, arginine methylation events have
a vastly reduced RBP annotation ratio (Fig 1D).
We next sought to define methyl-R clusters in full length protein
sequences. We therefore scanned across each modified protein
sequence to further identify proteins that contained multiple or
extended arrays over and above a 20–amino acid window (see the
Materials and Methods section). Using a cutoff of ≥3 proximal
modifications, we systemically defined 313 methyl-R arrays dis-
tributed across 273 proteins, containing a total of 1,600 arginine
methylation sites (Table S2). These arrays are distributed over
a broad size range up to 182 amino acids in length, with 102 proteins
having a methyl-R array longer than 20 residues (Fig S1A). Several
proteins contain multiple methyl-R arrays, such as the RNA pro-
cessing proteins EWSR1 and GAR1 (Fig 1E). Although RG motifs are
highly prevalent in many arrays, motif analysis of non-RG–driven
methylation arrays suggest that CARM1 may also mediate modifi-
cation clustering (Fig S1B).
We next sought to further characterize these targets of clustered
arginine methylation through comparison with their non-clustered
methyl-R counterparts. As highlighted above, methyl-R arrays
largely appear in regions of low structural complexity away from
classical function protein domains (Fig 1C). Proteins containing
these disordered regions have been shown to be under tight ex-
pression regulation in lower eukaryotes (Gsponer et al, 2008;
Vavouri et al, 2009). We therefore used the recent Genotype-Tissue
Expression (GTEx) gene expression dataset (Battle et al, 2017) to
observe whether this trend holds for human genes targeted by
clustered arginine methylation. In the GTEx dataset, each gene is
associated with multiple individual samples per tissue, allowing
characterization of expression variance across individuals within
multiple distinct cellular environments. We first established an
analytical framework to control for overall expression patterns of
targeted proteins (see the Materials and Methods section). We then
characterized the median expression values of clustered methyl-R
targets across 51 distinct tissues (clustered methyl-R proteins, Fig
1F, see the Materials and Methods section). For comparison, we
sampled the same number of genes from the non-clustered
methyl-R target genes, using a randomization protocol that gen-
erated a statistically indistinguishable control dataset (all methyl-R
proteins, Fig 1F). When comparing the interquartile range of these
two groups, we observed overall that proteins containing methyl-R
arrays have more tightly controlled gene expression variance
(middle panel, Fig 1F). Furthermore, the ratio of samples that show
overexpression for a given gene is lower for the methyl-R array
containing proteins (cutoff 1.25× and 1.5× median expression value,
rightmost panel Fig 1F). This analysis suggests that the two classes
of methylation target proteins discovered based on PTM clustering
also show a distinguished gene regulatory signature, with proteins
harboring methyl-R arrays under more tight expression regulation
across tissues.
Finally, we turned to examine patterns of genetic variation on
both classes of arginine methylation. Large-scale genome and
exome sequencing events have recorded the population preva-
lence (allele frequency) of millions of genetic variants in healthy
individuals (Lek et al, 2016). These allele frequencies can act as
proxies for the importance of specific amino acid residues affecting
critical protein functions (Woodsmith & Stelzl, 2017); in general,
critical residues should seldom be targets of missense mutation in
healthy individuals. Here, non-methylated arginines in targeted
proteins act as control for amino acid– and gene-specific mutation
rates. When comparing the proportion of mutated nonmodified
arginines to mutated methyl-arginines across the entire methyl-
ation dataset, we observe an increasing ratio indicating a relative
increase of mutated nonmodified arginines at increasing pop-
ulation prevalence (left panel, Fig 1G). This is to be expected, as the
exact identity of individual post-translationally modified residues
will generally be more critical than their nonmodified counterparts.
Interestingly, when repeating this analysis for arginines contained
within methyl-R arrays, this trend is substantially reduced (left
panel, Fig 1H). Furthermore, when we look at those methyl-R arrays
driven by RG motifs, the ratio of mutated modified arginines is
actually higher than its nonmodified counterpart at higher allele
frequencies (right panel, Fig 1H). This analysis indicates that ar-
ginine residues targeted by methylation present in arrays are more
variable in comparison with the bulk of methylated arginines
outside of methyl-R arrays regions. As such, in the context of ar-
ginine methylation, the exact amino acid identity at any position
where an arginine is present in these arrays is likely less critical
than of more isolated methyl-arginines counterparts.
In summary, based on sequence, regulatory and genetic sig-
natures this systematic in silico analysis provides evidence that
protein arginine methylation occurs in two classes; methylation
events that act in structurally complex regions but in relative
isolation to one another, and arrays of arginine methylation where
modifications may act in concert to regulate otherwise structurally
less defined, low information protein sequences. To understand
mechanistically how such extensive stretches of modifications can
function in the cell, we sought to experimentally characterize
a methyl-R array containing protein.
Identification of methyl-arginine binding proteins for highly
methylated hnRNP SYNCRIP
Using short chemically modified peptides in vitro has shown that
clusters of up to four methylated arginine residues distributed
across 20 amino acids can markedly increase methyl-binding
are the total methylation sites in each bar. (C) Bar graph showing the disorder distribution in 20–amino acid windows defined by the number of methyl-arginines they
contain. P values calculated using two sided Mann–Whitney–Wilcoxon test. (D) Bar graph showing the ratio of each protein class that are annotated as RBPs in each of the
three named studies. Dispersed methyl-arginine targets have ≥4 methylation sites but no clustering propensity. (E) Schematic diagrams of clustered methylation target
proteins. (F)Median expression, inter-quartile range and overexpression analysis (left pair: 1.25× median cutoff; right pair: 1.5× median cutoff) of clustered methyl-arginine
proteins and an equal-size randomly sampled comparison group from all other methylated proteins. P values calculated using two sided Mann–Whitney–Wilcoxon test.
(G) Bar chart showing the ratio of arginines that have an annotated missense variant in comparison with the ratio of methyl-arginines that have an annotated missense
variant at differing allele frequency cutoffs. (H) As in (G) but only using the arginines present in proteins targeted by clustered methyl-arginine windows (all data left, RG
driven windows right).
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domain interaction affinity (Tripsianes et al, 2011). Yet, it is presently
completely unclear whether low structural complexity regions use
extensivemethyl-R arrays stretching over dozens of amino acids for
multiple independent regulatory events or whether they cumula-
tively combine to increase the regulatory capacity of the entire
region. Not only are many of these large methyl-R arrays un-
amenable to in vitro peptide studies, it is of considerable interest
how large low structural complexity regions receive and transmit
information in the absence of a defined structure (Babu, 2016). We
therefore sought a highly methylated protein to be able to char-
acterize these extensive disordered regions in a larger context.
Previously, we identified candidate methyltransferases for a
large panel of target proteins using Y2H-Seq (Weimann et al, 2013).
We cross referenced proteins with the highest methylated argi-
nine density with the arginine methyltransferase interaction re-
sults and identified the hnRNP SYNCRIP (HNRNPQ), a robust PRMT1
interactor, in the intersection for detailed hypothesis-driven in-
vestigation (Fig S1B). SYNCRIP has a total of 18 putative RG
methylation target motifs spread across 106 amino acids within its
disordered C-terminal tail (Fig 2A and B, plus one R followed by an
A). 15 of the arginines have been shown previously to be meth-
ylated, spanning the entire length of its C-terminal tail both
in vitro and in vivo by PRMT1, seven of which by independent
studies (to date eight arginines observed in both the mono- and
dimethylated state, six in the mono-methylated state only, and
one on in the dimethylated state (Weimann et al, 2013; Hornbeck
et al, 2015; Larsen et al, 2016). Five arginines within the array have
been shown to be mutated in healthy individuals (Fig 2A, lower
panel and Table S3), and SYNCRIP shows very tight expression
regulation (Fig 2C), identifying it as a true representation of the
bioinformatic trends observed above.
Based on previous structural and biochemical studies of meth-
ylated arginines present in RG type repeats, we hypothesized the
C-terminal tail of SYNCRIP was required for binding to one or more
methyl-binding domains containing proteins (MeBPs). We screened
full-length protein-A–tagged SYNCRIP against a panel of 21 luciferase-
tagged putative or bona fide MeBPs in a high throughput immuno-
precipitation LUMIER-type assay (Hegele et al, 2012), allowing
a quantitative readout of multiple protein–protein interactions in
a 96-well format (see the Materials and Methods section). The vast
majority of MeBPs showed only a low signal in the LUMIER ex-
periment, representing background binding in the assay (Fig 2D). Al-
though two of the four Tudor domain–containing proteins tested
showed no interaction signal (green dots Fig 2D, SPF30 [SMNDC1] and
PHF19), SMN1 and PHF1 both showed high interaction readout clearly
distinct from the background distribution and were verified across
repeat assays (Fig 2D). SMN1 has been previously observed to interact
with multiple unrelated methylated arginine peptide sequences
(Friesen et al, 2001; Tripsianes et al, 2011; Liu et al, 2012) and reported
to interact with full-length SYNCRIP (Rossoll et al, 2002), but any
methylation dependency of the SYNCRIP–SMN1 interaction is un-
clear. The PHF1 Tudor domain has been structurally characterized in
complex with a histone 3–derivedmethyl-lysine peptide (Musselman
et al, 2012). As SYNCRIP has been reported to be both lysine and
arginine methylated (Fig 2A), we tested the methylation dependency
of both interactors bymutating residues critical for methyl binding in
the β-barrel Tudor structure of eachMeBP (TDmutants, Fig S2A and B
[Tripsianes et al, 2011; Musselman et al, 2012]). We tested these TD
mutants using the LUMIER approach alongside a disease-associated
mutant perturbing SMN1 dimerization that is critical for function (DD
mutant [Burghes & Beattie, 2009]). Mutations in the β-barrel struc-
ture markedly reduced the SYNCRIP interaction signal without af-
fecting the expression of either protein, suggesting that these
interactions are methylation dependent (TD mutants, Fig 2E). Al-
though SYNCRIP shows no self-interaction in this assay, robust SMN1
homo-oligomerization is required for a WT SYNCRIP binding signal
Figure 2. Identification of MeBPs that interact with
SYNCRIP.
(A) Schematic representation of methylation sites
annotated on the hnRNP SYNCRIP. Middle panel:
predicted protein disorder of SYNCRIP. Lower panel:
population max frequencies of genetic variation across
SYNCRIP taken from the Gnomad dataset. For ease of
representation, the y-axis is truncated to 4 × 10−4. (B)
Amino acid sequence and arginine modifications in the
C-terminal tail of SYNCRIP. (C) SYNCRIP GTEx expression
data: inter-quartile range values (left panel) and
overexpression ratios (right panel), for comparison with
data obtained for all clustered methyl-R target
proteins. (D) LUMIER experiments showing SMN1- and
PHF1-binding signals separate from the majority
distribution of other tested MeBPs. Green dots
represent non-binding Tudor domain–containing
MeBPs (SMNDC1 and PHF19). (E) LUMIER experiment
testing SMN1 and PHF1 mutants against WT SYNCRIP.
Input Western blot to show expression of protein A
tagged constructs. Error bars represent highest
and lowest observed values, two sided
Mann–Whitney–Wilcoxon test used to determine
statistical significance. *P < 0.05, **P < 0.01. TD, Tudor
domain; DD, dimerization domain.
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(DD mutant Figs 2E and S2C). This is in line with previous literature
suggesting that functional hnRNP particles are disrupted by muta-
tions in the SMN1 oligomerization domain (Burghes & Beattie, 2009).
In the SMN1 binding assay the TD mutant also showed a reduced
dimerization signal (Fig S2); therefore, we looked for further evidence
to support the methylation dependency of the interaction. Further-
more, as this study focused on the function ofmethyl-R arrays in protein
sequences, the likely methyl-lysine–dependent SYNCRIP-PHF1 interac-
tion was not pursued further.
SYNCRIP arginine methylation function in cell culture
To characterize the function of the SYNCRIP methyl-R array in cells,
we created HEK293T cells stably expressing HA-STREP tagged WT
and lysine to arginine mutant SYNCRIP. Here, we generated stable
cell lines expressing arginine to lysine mutated SYNCRIP with either
a small or intermediate number of the original arginines remaining
in the C-terminal tail (6 and 14 arginines, respectively. 6 Rs mutant,
remaining Rs: R409, R411, R413, R416, R475, R477. 14 Rs mutant, 5
mutants; R443K, R475K, R477K, R511K, R513K). We then immuno-
precipitated exogenously expressed WT and mutant SYNCRIP in
HEK293T cells to assay its methylation status and endogenous SMN1
binding. Immunoprecipitated WT SYNCRIP showed a strong signal
with the pan-methylated-arginine antibody in HEK293T cells,
a signal that was markedly reduced by the chemical methylation
inhibitor Adox (Fig 3A). In support of the methylation-dependent
nature of the interaction, precipitated endogenous SMN1 signal was
abolished in the presence of the inhibitor (Fig 3A). This pharma-
cologically inhibited methylation signal was mimicked by reducing
the number of arginines present in the C-terminal tail of SYNCRIP
(two rightmost lanes Fig 3A). Methylation was undetectable above
background levels on the 6R mutant, yet was partially rescued in
a mutant containing 14 arginines. In agreement with the pull-down
of WT SYNCRIP in the presence of Adox, mutant SYNCRIP containing
only six arginines in the C-terminal tail showed no SMN1 binding
above background levels, whereas the interaction was partially
rescued in the mutant containing 14 C-terminal tail arginines. This
experiment importantly shows that SYNCRIP can be methylated by
endogenous PRMTs under standard (nonstress) conditions and
is subsequently bound by endogenous SMN1 in a methylation-
dependent manner in mammalian cells.
PRMT1 has been previously shown to bind andmethylate SYNCRIP
in this C-terminal region in vitro, making it a strong candidate to
mediate the methylation observed here. PRMT1 knock-down is toxic
to cells and can cause substrate scavenging by other PRMTs, leading
to complications in obtaining and interpreting results from standard
genetic approaches (Dhar et al, 2013). To ascertain whether PRMT1
produced in live cells is active against SYNCRIP, we purified PRMT1
produced in HEK293T cells for use in an in vitro methylation assay.
Bacterially produced, and as such highly likely unmethylated, SYN-
CRIP was incubated with PRMT1 immunoprecipitated from HEK293T
cells using a STREP-HA tag. As can be seen in Fig 3B, PRMT1 could
bind to bacterially expressed, unmethylated SYNCRIP indepen-
dently of exogenous S-adenosyl-l-methionine (SAM), the substrate
required for methylation. This suggests that neither the cofactor
nor priming methylation events are absolutely required for PRMT1
binding. In the presence of SAM, the methyl-arginine signal greatly
increased, indicating SYNCRIP methylation by PRMT1 produced
from live cells (Fig 3B).
To characterize the SMN1-SYNCRIP interaction further, we used
the split-enhanced yellow fluorescent protein (EYFP) system to
assay this binding in live cells. SMN1 and SYNCRIP were tagged with
N and C-terminal sections of EYFP that do not individually fluoresce,
and co-transfected into HeLa cells. In this system, upon SYNCRIP
Figure 3. Characterization of SYNCRIP-SMN1
methylation–dependent interaction.
(A) Methylation dependency of SMN1-SYNCRIP
interaction. Immunoprecipitation (IP) of SYNCRIP-HA
from HEK293T cells expressing either WT SYNCRIP in the
presence or absence of Adox methylation inhibitor, or
SYNCRIP containing a reduced number of arginines. (B)
SYNCRIP binding and subsequent in vitro methylation
by HEK293T cell–produced PRMT1 in the presence of
cofactor SAM. (C) Confocal live micrographs of HeLa
cells expressing SYNCRIP and SMN1 each tagged with
a part of the EYFP fluorophore, Hoescht used to
visualize the nucleus. EYFP reconstitutes upon
SYNCRIP-SMN1 binding, allowing subsequent
visualization. Scale bar indicates 10 μm. (D) Under
nonstress conditions, WT SYNCRIP and a mutant
containing only six arginines show the same general
subcellular localization pattern. Upon heat shock,
stress granules (stained with TIA-1 stress granule
proteinmarker) form in bothWT andmutant expressing
cells. WT SYNCRIP is recruited to stress granules
significantly more efficiently than the six arginine
SYNCRIP mutant. Scale bar, 20 μm. (E) Quantification of
wild and mutant SYNCRIP recruitment to stress
granules. Number of cells with and without SYNCRIP-
positive stress granules was counted (n = 100) in four
independent experiments. Graph shows mean of four
independent experiments, error bars indicate standard
deviation. Two sided Mann–Whitney–Wilcoxon test
used to determine statistical significance. *P < 0.05.
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and SMN1 binding, the fluorophore fully reconstitutes allowing
direct visualization of the interaction’s sub-cellular localization
using live cell imaging. Here, we observed that SMN1 and SYNCRIP
interact both in the cytoplasm and nucleus (Fig 3C), with a slightly
strongerfluorescence in the cytoplasm that is in broad agreementwith
the localization of each protein when expressed alone or in combi-
nation (Fig S3). Together, these experiments provide further evidence
that SYNCRIP is methylated in HEK293T cells and that this methylation
leads to direct binding of SYNCRIP to SMN1.
We next moved to investigate the functional relevance of
methylated SYNCRIP in human cells. Multiple hnRNPs and SMN1
have been shown to play roles in stress granule formation in cell
culture (Guil et al, 2006; Zou et al, 2011). Furthermore, arginine
methylation itself has been implicated in stress granule biology;
however, whether it is a driving force for granule formation or more
a function of fully formed stress granules remains unclear (Xie &
Denman, 2011). We therefore looked to ascertain the subcellular
localization of WT and mutant SYNCRIP and endogenous SMN1
under stress and nonstress conditions. We observed stress granule
formation under heat shock when expressing both the WT and
mutant SYNCRIP constructs using the endogenous TIA-1 stress
granule marker protein (Fig 3D). Althuogh WT SYNCRIP was efficiently
recruited to stress granules upon heat shock, the SYNCRIP mutant
containing only six arginines was only poorly recruited (Fig 3E). Given
that SYNCRIP is methylated under nonstress conditions, these ex-
periments suggest that arginine methylation is a prerequisite for
efficient hnRNP recruitment to stress granules, not a function of the
granule stress response. Although we could observe overexpressed
SMN1 recruitment to stress granules, we could not observe endog-
enous recruitment under several stress conditions (Fig S4).
Detailed dissection of methylated and unmethylated arginine
array in SYNCRIP
Having validated the importance of the SYNCRIP methyl-R array for
SMN1 interaction in cells, we sought to systematically dissect the
binding mechanisms of the entire disordered region in both its
unmodified and modified states in full. To do so, we leveraged the
two distinct arms of the arginine methylation regulatory machinery
described above, with the methyltransferase PRMT1 and the
methyl-binding protein SMN1 acting as functional readouts for the
unmodified and modified disordered regions, respectively. Using
these two proteins as in-cell molecular probes in the quantitative
LUMIER assay would then allow systematic dissection of binding
mechanisms of this low structural complexity region.
As the permutations of 19 arginines to lysine mutations is un-
feasible to address experimentally (219, >500,000 for position de-
fined permutation), we sought to rationally design mutants based
on the cluster proximity of the RG repeats within the array (Fig S5).
Using site-directedmutagenesis, we generated a total of 37mutants
in the context of the full-length protein that can be designated into
three general subgroups: The first group contains a single, con-
tinual stretch of the WT arginine residues, but the number of ar-
ginines and the position of the continual stretch varies across the
entire tail (top panel, Fig 4A). Conversely, the second group contains
a single, continual stretch of arginine to lysine mutants, but the
number and position of lysinemutants in the C-terminal tail is varied
(middle panel, Fig 4A). The final smaller group has noncontiguous
patches of arginine to lysine mutations distributed across the
C-terminal tail (lower panel, Fig 4A).
In agreement with the SYNCRIP mutants used in the endogenous
SMN1 immunoprecipitation experiment, the reactivity of a subset of
these SYNCRIP mutants with the pan-methyl-arginine antibody
correlated well with overall SYNCRIP arginine content. Removing
any individual arginine cluster within the array did not abolish
methyl-arginine signal, rather the reduction in signal correlated
qualitatively with the reduction inmethylatable residues (Fig S6). As
this SYNCRIP arginine to lysine mutant panel can be methylated in
a graded manner under standard conditions, it can act as a good
proxy for reduced methylation of full-length SYNCRIP in cultured
cells. We therefore screened each full-length mutant for a func-
tional readout of both the unmodified (PRMT1) andmodified (SMN1)
states of this unstructured region.
Both PRMT1 (Fig 4B) and SMN1 (Fig 4C) LUMIER experiments
showed good reproducibility, with mutant expression comparable
withWTSYNCRIP and exhibiting low variability (Fig S7). AlthoughSMN1
showed only a weak signal for PRMT1 binding that was comparable
with controls, PRMT1 shows a very strong self-interaction signal, in
agreement with previous knowledge on its homo-dimerization
(Zhang & Cheng, 2003; Thomas et al, 2010; Weimann et al, 2013).
Through comparing the binding scores with the mutant sequences,
several trends are immediately clear (Heatmaps next to mutant
schematic diagrams, Fig 4A). Mutating either N or C-terminal argi-
nines ablated neither SMN1- nor PRMT1-binding completely, only
sequentially mutating residues from both terminal groups to leave
a small central arginine patch eventually reduced binding to back-
ground levels (top panel, Fig 4A). Furthermore, mutation of any in-
dividual arginine patch did not reduce the binding signal to
background levels with central lysine mutants tolerated in the
context of flanking arginines (middle and lower panel, Fig 4A). These
experiments suggest a model whereby both the modified and un-
modified RG repeat regions mediate their interactions cumulatively,
showing an increased binding signal up to restoration of the full 19WT
arginine residues (grey–blue color code in Fig 4B and C).
To systematically test whether both modified and unmodified
regions follow this overarching model of cumulative arginine de-
pendency, we then grouped the mutants based solely on the
number of arginines that remain in the C-terminus. In good
agreement with this model, there is a strong positive correlation
between binding score and number of arginines for both SMN1 and
PRMT1 (Fig 4D and E). To dissect this further, we then split the
SYNCRIP mutants into two sub-categories; one group in which
all arginines were present in a contiguous linear sequence, and
a second where lysine mutants interrupted the sequence of
remaining arginines (noncontiguous). To cover the full spectrum of
mutant subgroups, overlapping levels of total arginine were used
to further divide each category. Interestingly, although methyl-
arginine reader SMN1 shows little difference between the two
groups (Fig 4F), the PRMT1-binding signal indicates a clear pref-
erence for contiguous arginine stretches, irrespective of the total
arginine content (Fig 4G). Importantly, this model refinement still
falls within the general cumulative argininemechanism, asmutants
with 15 to 18 arginines present in noncontiguous mutants still show
higher PRMT1 binding than mutants with 10–13 contiguous arginine
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residues (P = 0.02, one-Sided Mann–Whitney–Wilcoxon test, Fig 4G).
Therefore, through leveraging the arginine methylation machinery
as in-cell molecular probes, we can develop an overall model of
cumulative methyl binding across more than 100 amino acids of
disordered protein sequence, and furthermore, for the first time,
differentiate overarching binding preferences of the unmodified
and modified RG repeats.
Disordered protein sequences inherently contain little protein
structural information, and as such are difficult to experimen-
tally investigate. Here, we used a functional readout for both the
methyl independent (PRMT1) and methylated (SMN1) states to
show, first, how a large array of RG repeats can be used to generate
a cumulative binding capacity within disordered regions and,
second, how PTMs can co-opt these same regions using distinct
binding preferences to produce a functional output.
Discussion
Here, we highlight the dual mechanisms arginine methylation uses to
regulate protein function. We identified hundreds of candidates an-
notated with methyl-R arrays and investigated in detail one of the
longest methylated arginine stretches identified, distributed across 19
arginines within the disordered C-terminal tail of the hnRNP SYNCRIP.
Figure 4. Systematic dissection of arginine
requirement for PRTM1 and SMN1 binding to SYNCRIP.
(A) Schematic diagram representing the R to K full-
length mutant constructs and their binding signal in
each experiment (white-red heatmap next to
schematics). Light green boxes represent R patches
where only three of the four arginines were mutated to
lysines post-sequence verification. PRMT1 (B) or SMN1
(C) binding signals in medium throughput LUMIER
experiment assaying multiple R to K mutations on the
binding of full-length SYNCRIP. SMN1- (D) or PRMT1- (E)
binding signal box plots for each group of R to K
SYNCRIP mutants. Groups designated by the total
number of remaining C-terminal arginines. SMN1- (F) or
PRMT1- (G) binding signal box plots for subgroups of R
to K SYNCRIP mutants. Each subgroup designated by
the total number of arginines in either a contiguous or
noncontiguous sequence. Numbers at the top of each
blot represent the number of data points in each box
plot. One sided Mann–Whitney–Wilcoxon test used to
determine statistical significance. *P < 0.05, **P < 0.01.
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As much as 40% of eukaryotic proteomes are annotated as dis-
ordered protein sequence (Potenza et al, 2015). Proteins harboring
such regions have well-established roles in cellular signaling and
have been implicated in multiple disease processes (Babu, 2016).
However, understanding the function of such long unstructured
regions in a cellular environment has proved challenging.
To tackle this problem, we generated a large set of full-length
SYNCRIP mutants, allowing investigation into these methyl-R arrays
in the context of the full-length protein in a quantitative immu-
noprecipitation assay. This experimental setup does not provide
the detailed biophysical data of in vitro peptide studies; however,
the number and length of mutants allows overarching in vivo
binding principles to be observed that would otherwise be refractory
to experimental investigation. In stark contrast to the canonical
single PTM–single function paradigm, no individualmodified arginine
is absolutely required for an interaction in cultured cells. This trend
also holds for the modification-independent RG repeat functional
interaction with PRMT1. Furthermore, the interaction signal ob-
served for modified and unmodified disordered sequences in-
creases as arginines are restored up to the 19 present in WT SYNCRIP.
This finding suggests that the methyl-R arrays identified proteome
wide are functionally driven by a requirement for tunable protein
interactions.
We could also further refine this cumulative RG motif re-
quirement to be able to propose distinct models for both the
modified and unmodified unstructured arrays that rely on the
ability of disordered regions to adopt multiple conformations
within the cell. Here, we show that PRMT1, but not SMN1, sub-
stantially prefers contiguous runs of RG motifs within an array. The
biophysical properties of PRMT1, SMN1, and their RG peptide rec-
ognition mechanisms give clues as to the likely origin of these
mechanistic differences. Both SMN1 and PRMT1 are known to oli-
gomerise into higher order structures providing multiple binding
sites for each (methylated) arginine in each oligomer (Zhang &
Cheng, 2003; Burghes & Beattie, 2009; Martin et al, 2012). These
oligomers are absolutely required for normal functioning and mu-
tants disrupting the SMN1 basic dimer lead to disease phenotypes
(Burghes & Beattie, 2009). Furthermore, PRMT1 dimerization is
strongly interlinked with AdoMet binding and catalytic activity
(Thomas et al, 2010; Zhou et al, 2015), therefore detailed biophysi-
cal experiments are required to further disentangle dimerization
requirements at each step of the methylation reaction. However,
these oligomeric structures allow complex binding mechanisms and
provide the basis for the general mechanisms proposed here.
A single SMN1 Tudor domain monomer can only accommodate
binding to one methylated arginine at any given time, yet the
arginine-binding β-barrel domain still shows an increased affinity
for a multi-methylated peptide (Tripsianes et al, 2011). Furthermore,
as the Tudor domain lacks contacts to residues adjacent to the
methylated arginine–glycine mark (Tripsianes et al, 2011), repeated
methyl-arginine binding can be independent of local sequence
context. Therefore, repeated binding does not necessarily require
sequential modification along a protein sequence, only methyl-
arginines close in 3D space as present here in the long disordered
tail region. In the context of multiple Tudor domains within an SMN1
oligomer, this “one-out one-in” binding mechanism would clearly
favor long, multiply modified flexible substrates as each binding
pocket could be simultaneously occupied or rapidly rebind dissoci-
ated methylated arginines (Fig 5A). In a model with independent
recognition events of a single modified residue, multiple binding
pockets would aid rapid rebinding of dissociated methylation groups.
Furthermore, the interaction would be less sensitive to the linear
placement of methylations along a disordered tail that can adopt
many conformations, and would consequently mainly be dependent
on the total modification level in a confined 3D space. Although
single-methylated arginine residues not present in RG motifs
have also been shown to recruit SMN1 (Zhao et al, 2016), we
hypothesize that many of the long RG arrays identified here will
follow similar cumulative arginine-driven binding models.
In contrast to a singlemethyl-arginine binding to a Tudormonomer,
the PRMT1 monomer contains multiple putative RG binding acidic
grooves, three of which have been shown to bind a triple-RGG con-
taining peptide with higher affinity than a single-RGG–containing
peptide (Zhang & Cheng, 2003). This necessarily constrains the argi-
nines in a physically consecutive peptide as multiple motifs across
a linear sequence are simultaneously involved in a binding event (Fig
5B). As such, sequence deviation would likely lead to a lower affinity
and reduced catalytic activity, in line with previous observations
(Zhang&Cheng, 2003). All of the long SYNCRIP substrates assayed here
contain many multi-RG peptides within a single disordered protein
sequence, providing multiple opportunities for PRMT1 oligomer recog-
nition. However, a noncontiguous mutant PRMT1 recognition event is
more likely to involve disruptive arginine to lysine flanking mutants than
a contiguous mutant with the same arginine content, thus providing
a less optimal substrate and the lower binding signals observed here.
Given the lengthof theRG-containingarrays identifiedhere, it is plausible
that both monomers within a PRMT1 dimer are involved in this recog-
nition event and act in tandem to increase binding strength (Fig 5B).
Long, multiply modified disordered substrates such as the SYN-
CRIP C-terminal tail fall outside of the classical structure–function
paradigm and as such are refractory to direct visualization using
standard structural and biochemical approaches. As such, novel
approaches are required to untangle exactly how these regions are
recognized by the cellular machinery. The genetic approach taken
Figure 5. Model of SMN1 methyl-arginine dependent and PRMT1 arginine
dependent SYNCRIP interactions.
(A) Multiple Tudor domains in an SMN1 oligomer independently interact with
individual methylated arginine moieties within the flexible SYNCRIP C-terminal
tail. (B) Multiple sequential arginines in the flexible SYNCRIP tail recognized
simultaneously by a PRMT1 dimer.
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here provides insight into how such long stretches of methyl-
arginine residues function within the cell and further how short
peptide binding mechanisms translate into overall interaction
preferences in the context of a full-length protein. Thesemodels also
provide plausible links to the bioinformatic trends we observed for
methyl-R array–containing proteins. As protein interactions are
driven by protein concentration, tunable interaction mechanisms
such as the one described here require tight expression regulation
aswe observed in the GTEx dataset (Fig 1G). Furthermore, if individual
modifications within an array are not absolutely critical for overall
function, mutations are less likely to be damaging and subsequently
more likely to be observed in population-level genetic data (Fig 1H).
This study represents the most comprehensive dissection of
extensive low structural complexity regions present proteome wide
to date, and furthermore highlight how the cell uses two distinct
bindingmechanisms within these disordered sequences to achieve
a similar overarching effect; namely a cumulative contribution of
each RG repeat to binding strength.
Experimental procedures
PTM data collation and analysis
Dataset collation was undertaken as in (Woodsmith et al, 2013).
Briefly, data for each PTM was obtained from PhosphoSitePlus
(Hornbeck et al, 2015) and integrated with publicly available
datasets to obtain a nonredundant list of 13–amino acid sequences
(13mers). The central amino acid is annotated as modified in each
13mer and only modified lysine or arginine residues were taken
forward to the final analysis (Table S1).
Iupred disorder analysis
Each RefSeq protein sequence in the analysis was analyzed using the
Iupred disorder prediction software (Doszta´nyi et al, 2005), 0.5 was set
as a cutoff to binarise each amino acid into ordered or disordered.
RBP annotation
RBP annotation has been shown to be variable depending on
the experimental set-up. We therefore took three independent
experiment studies (Baltz et al, 2012; Castello et al, 2012; Conrad
et al, 2016) for the initial analysis. To annotate the RG array–
containing proteins as RBPs or not for Fig 1D, we used the list given
in (Gerstberger et al, 2014).
Methyl-R array extraction
>25,000 proteins sequences were computationally scanned in
overlapping 20–amino acid windows in the N to C terminus di-
rection. If multiple PTM annotated isoforms were available, the
most highly annotated isoform was taken forward. The start of any
methyl-R array was defined as any sequence that contained three
or more methylated arginines in a 20AA window. The array was then
continued unless a 50–amino acid gap between the start of the
array and the next methyl-R triplicate appeared. A list of all arrays
extracted can be found in Table S2.
Motif analysis of non-RG–driven methylation arrays
We extracted all non-RG methylation sites from arrays driven by
methyl-non-RGs (Fig S1B). We then used icelogo with default
settings (Maddelein et al, 2015) to generate a consensusmotif, using




gct for all analyses downloaded from https://gtexportal.org/home/
datasets. To aid statistically robustness, we only calculated the
median and variance of gene expression for identifiers with >10
samples per tissue, leaving a maximum of 51 tissues per gene
identifier. We then used the distribution of the median expression
values for the methyl-R array genes as a control for further com-
parative analysis. We randomly sampled the overall methylation
dataset for the same number of genes as present in the methyl-R
array target gene set. We then extracted their data from the GTEx
dataset, ensuring that for each randomization the distribution of the
median expression values across all tissues was statistically in-
distinguishable from that observed for the methyl-R array genes
(example of distribution comparison Fig 1F, left panel). We then
compared the distribution of the gene expression variance from the
same random sample (Figs 1F and 3, rightmost panels). We repeated
the random sampling protocol 100 times, observing the same out-
come after each randomization.
Gnomad dataset analysis
We used gnomad.exomes.r2.0.1.sites.vcf.gz for all analyses down-
loaded from gnomad.broadinstitute.org/downloads, only taking
forward the Gnomad annotated isoform that corresponded to the
arginine modified isoform from the PTM dataset collation. As
a measure for the likelihood of any mutation occurring at a given
arginine, we summed the allele frequencies for all mutations per
codon across all identifiers. For any given allele frequency cutoff,
we then calculated the ratio of the proportion of mutated non-
modified arginines to the proportion of mutated modified argi-
nines. We repeated this analysis for three datasets; all proteins
targeted by arginine methylation, all proteins targeted by methyl-R
arrays, and all proteins targeted by methyl-R arrays driven by
arginines-glycine motifs.
Cell culture
All cell lines weremaintained in a humidified incubator at 37°C with
5% CO2. HEK293T cells were used for all immunoprecipitation ex-
periments. For cellular stress experiments, HeLa cells were used for
quantification and HeLa Kyoto cells were used for confocal imaging
and were grown in DMEM high glucose GlutaMAX (Invitrogen)
supplemented with 10% FCS and 10 μg/ml gentamicin. For split-
EYFP experiments and localization experiments HeLa cells were
grown in DMEM containing 10% FCS.
LUMIER-type experiments
MeBP and SYNCRIP ORFs were transferred to either firefly luciferase-
V5 fusion vectors (pcDNA3.1V5-Fire) or protein-A fusion vectors
(pcDNA3.1PA-D57), using standard gateway cloning procedures.
For co-IP assays, 3 × 104 HEK293 cells were transiently cotrans-
fected with firefly (75 ng) and protein A (PA; 75 ng) plasmid DNA
using Lipofectamine 2000 (Invitrogen) in each well of a 96-well
plate. Cells were lysed 36 h after transfection in 100 μl Hepes buffer
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(50 mM Hepes pH 7.4, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1%
Triton X-100 and protease inhibitor [11051600; Roche]) for 30 min at
4°C. Protein complexes were precipitated from 80 μl cleared cell
extract in IgG-coated microtiter plates for 2 h at 4°C and rapidly
washed three times with 100 μl ice-cold PBS. The binding of the
firefly-V5–tagged fusion protein (co-IP) to the PA-tagged fusion
protein was assessed by measuring the firefly luciferase activity in
a luminescence plate reader (Beckmann D TX800, Bright-Glo Lucif-
erase Assay [Promega]). Assays were performed as triplicate trans-
fections. For small-scale LUMIER experiments, the raw output
intensities are displayed for each triplicate. For the methyl-binding
protein experiment (Fig 3), the background for SYNCRIP-FIREFLY was
calculated as an average of the three lowest reported luminescence
readings, converted to a Log(2) scale. This was then subtracted from
each reported methyl-binding protein value to be able to observe PA
clones that reported robust signals above the background distri-
bution. Two PA proteins (CBX1 and BPRF1) were found to be “sticky” in
this experimental setup and were subsequently excluded from
further analysis (i.e., they showed interactions with a large amount of
unrelated proteins, data not shown). For the large mutant SYNCRIP
experiments, a triplicate of PA untransfected wells were used to
estimate the background Log(2) signal in each plate. This was then
subtracted from each mutant output value and the Log(2) signals
plotted. Furthermore, we checked the observed interaction distri-
bution could not be explained by a simple linear regression of input
against output values (R-squared values SMN1-FIREFLY = 0.0196,
PRMT1-FIREFLY = 0.0488). Noninteracting controls used to indicate
background binding in the large mutant SYNCRIP experiment were
U2AF1, BAT3, and SPATA24.
Stable cell line generation
SYNCRIP- and PRMT1-tagged constructs were generated in the
pcDNA5/FRT/TO/HA STREP vector using standard gateway cloning
(Invitrogen) and transfected into HEK293 cells cultured in DMEM +
FCS. 48 h after transfection, transformed cells were selected
through incubation with 50 μg/ml hygromycin for 12–20 d. Indi-
vidual colonies were picked and tested for equivalent protein
expression induced with 1 μg/ml doxycyclin for 24 h, before
pooling.
Endogenous SMN1 immunoprecipitation experiments
For each individual immunoprecipitation, 2.5 × 106 stable HEK293
cells were seeded in DMEM + FCS (1 μg/ml doxycyclin). Each dish
was then incubated with the required concentration of Adox or
DMSO vehicle control for 24–36 h. Cells were then lysed in Hepes
buffer (as above for LUMIER-type experiments), and incubated with
pre-blocked anti-HA beads (1% BSA, overnight at 4°C) prior to 3×
washing in ice cold lysis buffer. Beads were then resuspended in
1.5× sample buffer (18 mM Tris-Cl pH 6.8, 0.6% SDS, 3% glycerol, 1.5%
β-mercaptoethanol, and 0.003% bromophenol blue) before elec-
trophoresis and Western blot analysis.
In vitro SYNCRIP production
GST-tagged SYNCRIP was expressed in 12.5 ml OverNight Express
Autoinduction TB-Medium (+Amp, +CAM) at 37°C (150 rpm) for 20 h.
The bacteria culture was then centrifuged at 1,800 g (4°C) to collect
the cell pellet. The pellet was then resuspended in 1.85 ml lysis
buffer (50 mMHepes, 150 mMNaCl, 5% glycerol, 1 mM EDTA, 0.5% Brij
58, 1 mg/ml lysozyme, 2 mM DTT) and incubated on ice for 30 min
350 μl Bezonase solution (20 mMHepes, pH 8.0, 2 mMMgCl2, 0.1 U/μl
benzoase) was then added to the lysate before a further 30 min
incubation at 4°C and a final centrifugation step at 15,000 g for
30 min at 4°C before the supernatant being stored on ice until
further use.
PRMT1 beads preparation
6 × 106 HEK293 cells expressing either PRMT1 were collected, washed
once in ice cold PBS, then incubated on ice for 30 min in 0.5 ml lysis
buffer (50 mM Hepes pH 8.0, 150 mM NaCl, 10% glycerol, 1% Triton-X
100). The lysate was then centrifuged at 15,000 g, 30 min, 4°C before
the supernatant being inoculated for 1 h with pre-washed Strep-
Tactin beads suspension at 4°C. PRMT1 beads were then washed
four times in lysis buffer before being stored on ice until further use.
SYNCRIP methylation assay
PRMT1 beads were mixed with SYNCRIP bacterial lysate (2:1 by
volume) and inoculated shaking (300 rpm) for 2 h at 30°C either in
the absence or presence of 20mM exogenous SAM. The supernatant
was removed and stored on ice until further use, remaining beads
were resuspended in sample buffer and heated for 5 min at 95°C
before storage at −20°C before Western blot analysis. Methylation
was detected using anti-mono and dimethyl arginine antibody
([7E6], ab412; Abcam, raised against asymmetrical NG/NG-dimethyl
arginine).
Localization experiments
HeLa cells were transfected with FuGene transfection reagent at 3:1
ratio of DNA:reagent using a standard protocol. Live cell imaging of
split-EYFP was undertaken on MatTek dishes 22 h post-transfection
with 10min of Hoescht incubation before visualization. For individual
and colocalisation experiments, cells seeded on glass coverslips
were fixed 16 h post-transfection with 4% paraformaldehyde. EYFP
signal was detected using a chicken anti-GFP antibody (ab13970;
Abcam) followed by an anti-chicken Alexa-Flour-488 secondary
(Thermo Fisher Scientific). PA signal was detected using rabbit IgG
(Santa Cruz) followed by anti-rabbit Alexa-Flour-555 secondary
(Thermo Fisher Scientific).
Confocal microscopy and image processing for cellular
localisation experiments
Confocal laser scanningmicroscopywas performed on a Fluoview 1000
confocal microscope (Olympus) equipped with a UPLSAPO60/1.3 nu-
merical aperture silicon immersion oil immersion lens. Images were
taken with the following excitation (Ex) and emission (Em) settings:
Hoechst Ex: 405 nm diode laser (50 mW) Em: 425–475 nm; GFP, Alexa-
Fluor488 Ex: Multi-Line Argon laser 488 nm (40 mW) Em: 500–545 nm;
EYFP, Ex: Multi-Line Argon laser 515 nm (40 mW) Em: 530–545 nm;
AlexaFluor555 Ex: 559 nm diode laser (20 mW) Em: 570–625 nm.
Cellular stress experiments
To avoid formation of stress granules by overexpression, low
amounts (10 ng per 24-well) of DNA coding for EYFP-SYNCRIP (WT/
6R) was cotransfected with an empty vector (pcDNA3.1-hygro(+);
490 ng per 24-well) using Turbofect (Fermentas) according to the
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manufacturer’s instructions. Stress treatment was carried out ei-
ther by heat shock (1 h at 44°C) or by addition of 0.5 mM sodium
arsenite (30 min at 37°C). Cells were immediately fixed in 3.7%
formaldehyde in PBS for 7–10 min and permeabilized with 0.5%
Triton X-100 in PBS. Cells were blocked for 10 min in blocking buffer
(1% donkey serum in PBS/0.1% Tween-20) and incubated with
primary antibody (monoclonal mouse anti GFP [for detection of
YFP-SYNCRIP]: Hybridoma was kindly provided by A. Noegel, Co-
logne, Germany (Noegel et al, 2004); purified antibody was a gift
from M. Kiebler, LMU, Munich. Mouse anti SMN: BD [610646], goat
anti ia-1 [G3], Santa Cruz [sc-166247]), and secondary antibodies
(Invitrogen/Molecular Probes) diluted in blocking buffer. Washing
steps were performed with PBS/0.1% Tween-20. Nuclei were stained
with DAPI (0.5 μg/ml; Sigma-Aldrich) and mounted in prolong di-
amond mounting medium (Invitrogen) before analysis by confocal
fluorescence microscopy.
Confocal microscopy and image processing for cellular stress
experiments
Images for colocalization of YFP-tagged SYNCRIP with stress granule
markerswere acquired by confocalmicroscopy on an inverted Leica SP8
microscope (Bioimaging core facility of the Biomedical Center),
equipped with lasers for 405, 488, 552, and 638 nm excitation. Images
were acquired with a 63 × 1.4 oil objective, image pixel size was 59 nm.
The following fluorescence settings were used for detection: DAPI:
419–442 nm, Alexa 488/YFP: 498–533 nm, Alexa 555: 598–634, Alexa 647:
650–700 (for quadruple stain) or 649–698 (for triple stain). Recording
was sequential to avoid bleed-through using a conventional photo-
multiplier tube. Confocal images were acquired using LAS X (Leica) and
processed using Image J software applying linear enhancement for
brightness and contrast. For illustration of the localization of SMN in
response to arsenite treatment, a stack of 10 (unstressed) or 12
(+arsenite) sections in 300 nm step size was acquired and projected
using the maximum intensity projection function in the LAS X software.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800178.
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